Skip to main content

PPH

ETF
—
—

Performance overview

PPH Price
Price Chart

Forward-looking statistics

Beta
0.48
Risk
12.63%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

—

Fund info

—

Investing methodPassively Managed
DiversifiedNo
Expense ratio0.35%
Asset classUnknown

Company info

Sector—
Industry—
Website—
AUM—

Security info

ExchangeNASDAQ
Type of shareN/A
Earnings per share (EPS)—
Dividend per share$2.43
Revenue per share—
Avg trading volume (30 day)$43M
Avg trading volume (10 day)$38M
Put-call ratioN/A

Macro factor sensitivity

Growth+1.1
Credit+1.6
Liquidity-0.2
Inflation-1.2
Commodities+0.0
Interest Rates-0.9

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend dayJuly 1, 2025

News

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

The VanEck Pharmaceutical ETF (PPH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market.

Zacks Investment Research (May 21, 2025)
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks

As the drug industry is in the middle of a growing policy maelstrom in Washington, D.C., investors are closely watching pharmaceutical ETFs to measure market sentiment and ride out the emerging volatility.

Benzinga (May 8, 2025)
Final Trade: MSTR, PPH, TLT, MCD

The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.

CNBC Television (January 7, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free